ODI Pharma Group (“ODI”) was founded in 2018 with the goal to improve patients access to medicinal cannabis. Based on its European network, subsidiaries and partners, ODI is a producer and representative of pharmaceutical cannabis finished products under governmental supervision and regulation with a focus on distribution to medicinal markets, initially targeting Eastern Europe. ODI’s products are to be sold to clients and patients through ODI's relationships to wholesale medical distributors representing nearly all of Eastern Europe’s hospitals, clinics and pharmacies. ODI does not strive to cultivate the raw product itself, but decided to team up with the global leaders in the industry to source highest quality product for ODI’s and its client's brands, thereby ensuring reliability, consistency and professionalism.